First Turn Management, LLC
DEL MAR, CA · CIK 1993440 · 13F filing filed 2026-02-13
SEC-registered investment adviser since 2023 · limited liability company
- Assets managed$900.1m
- Staff4 · 4 in investment roles
- Main clients (by assets)Sovereign wealth funds 90%, Private funds 10%
- Private funds2 (2 hedge) · $36.3m gross assets
- Main officeSolana Beach, CA
- Form ADV · 2026-03-25SEC adviser record
- Legal entityFIRST TURN MANAGEMENT, LLC (US)
- Kindhedge funds, institutions
- Others nearbySolana Beach, CA
As an employer
- Offices in1 country
- Private fundshedge 2
$875.2m
reported value
+31.4% vs Q3 2025
33positions
47.3%in top 10
12 new
8 added
10 reduced
8 sold out
vs Q3 2025
Holdings, Q4 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ABIVAX SA ABVX | $51.4m5.87% | Added +89.4k |
| REVOLUTION MEDICINES INC RVMD | $50.8m5.81% | Reduced -4.7k |
| INSMED INC INSM | $46.0m5.26% | Reduced -55.5k |
| BRIDGEBIO PHARMA INC BBIO | $45.5m5.20% | Added +5.7k |
| MIRUM PHARMACEUTICALS INC MIRM | $38.0m4.35% | Reduced -89.0k |
| AXSOME THERAPEUTICS INC AXSM | $37.8m4.32% | Added +54.3k |
| NUVALENT INC COM | $37.1m4.24% | Reduced -26.1k |
| XENON PHARMACEUTICALS INC XENE | $35.8m4.10% | Unchanged |
| APOGEE THERAPEUTICS INC COM | $35.8m4.10% | Added +72.0k |
| TERNS PHARMACEUTICALS INC COM | $35.2m4.03% | New |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $31.3m3.58% | Added +176.5k |
| UNITED THERAPEUTICS CORP DEL UTHR | $31.0m3.54% | Reduced -21.7k |
| VERA THERAPEUTICS INC VERA | $30.5m3.48% | Added +247.2k |
| COGENT BIOSCIENCES INC COGT | $29.3m3.35% | New |
| ASCENDIS PHARMA A/S SPONSORED ADR | $28.1m3.21% | Reduced -14.5k |
| GUARDANT HEALTH INC GH | $27.7m3.17% | New |
| ROIVANT SCIENCES LTD ROIV | $25.8m2.94% | Added +227.1k |
| IDEAYA BIOSCIENCES INC IDYA | $25.0m2.86% | New |
| VIRIDIAN THERAPEUTICS INC VRDN | $21.5m2.46% | New |
| FULCRUM THERAPEUTICS INC FULC | $21.4m2.45% | New |
| CYTOKINETICS INC CYTK | $20.7m2.36% | Added +70.9k |
| SCHOLAR ROCK HLDG CORP SRRK | $20.3m2.31% | New |
| ARGENX SE ARGX | $19.6m2.23% | Reduced -15.5k |
| NATERA INC NTRA | $18.5m2.12% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $16.4m1.88% | Reduced -149.2k |
| KYMERA THERAPEUTICS INC KYMR | $16.1m1.84% | Reduced -71.3k |
| RHYTHM PHARMACEUTICALS INC RYTM | $15.7m1.79% | New |
| OLEMA PHARMACEUTICALS INC OLMA | $15.4m1.76% | New |
| ARCUS BIOSCIENCES INC RCUS | $13.5m1.54% | New |
| DISC MEDICINE INC IRON | $12.2m1.39% | Reduced -244.5k |
| PRAXIS PRECISION MEDICINES I PRAX | $10.5m1.20% | New |
| UNIQURE NV QURE | $7.7m0.88% | New |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $3.5m0.40% | Unchanged |
Sold out since Q3 2025
| Security | Value then |
|---|---|
| MERUS N V MRUS | $35.0m372.0k shares |
| ARCELLX INC ACLX | $25.8m313.7k shares |
| NEUROCRINE BIOSCIENCES INC NBIX | $25.5m181.9k shares |
| AKERO THERAPEUTICS INC AKRO | $18.9m397.0k shares |
| ENLIVEN THERAPEUTICS INC ELVN | $16.0m783.4k shares |
| JANUX THERAPEUTICS INC JANX | $15.6m639.7k shares |
| ADMA BIOLOGICS INC ADMA | $11.9m808.7k shares |
| HARROW INC HROW | $7.7m160.2k shares |